193 related articles for article (PubMed ID: 9716792)
1. Raynaud's Phenomenon and Helicobacter Pylori Infection.
Gasbarrini A; Serricchio M; Tondi P; De Luca A ; Franceschi F; Ojetti V; Pola R; Dal Lago A ; Flore R; Santoliquido A; Gasbarrini G; Pola P
Int J Angiol; 1998 Aug; 7(4):307-9. PubMed ID: 9716792
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.
Gasbarrini A; Massari I; Serricchio M; Tondi P; De Luca A; Franceschi F; Ojetti V; Dal Lago A; Flore R; Santoliquido A; Gasbarrini G; Pola P
Dig Dis Sci; 1998 Aug; 43(8):1641-5. PubMed ID: 9724144
[TBL] [Abstract][Full Text] [Related]
3. [Raynaud syndrome and eradication of Helicobacter pylori].
Csiki Z; Gál I; Sebesi J; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2827-9. PubMed ID: 11202119
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of Helicobacter pylori eradication on migraine.
Gasbarrini A; De Luca A; Fiore G; Gambrielli M; Franceschi F; Ojetti V; Torre ES; Gasbarrini G; Pola P; Giacovazzo M
Hepatogastroenterology; 1998; 45(21):765-70. PubMed ID: 9684130
[TBL] [Abstract][Full Text] [Related]
5. [Methylphenidate and secondary Raynaud's phenomenon].
Iglesias Otero M; Portela Romero M; Bugarín González R; Ventura Victoria MA
Semergen; 2013 Sep; 39(6):330-4. PubMed ID: 24034762
[TBL] [Abstract][Full Text] [Related]
6. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
[TBL] [Abstract][Full Text] [Related]
7. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Anderson JE; Held N; Wright K
Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
[TBL] [Abstract][Full Text] [Related]
8. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
DiGiacomo RA; Kremer JM; Shah DM
Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria.
Di Campli C; Gasbarrini A; Nucera E; Franceschi F; Ojetti V; Sanz Torre E; Schiavino D; Pola P; Patriarca G; Gasbarrini G
Dig Dis Sci; 1998 Jun; 43(6):1226-9. PubMed ID: 9635612
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon of the lung.
Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Kato S; Ritsuno H; Ohnuma K; Iinuma K; Sugiyama T; Asaka M
Helicobacter; 1998 Dec; 3(4):278-82. PubMed ID: 9844069
[TBL] [Abstract][Full Text] [Related]
12. Enalapril in Raynaud's phenomenon.
Janini SD; Scott DG; Coppock JS; Bacon PA; Kendall MJ
J Clin Pharm Ther; 1988 Apr; 13(2):145-50. PubMed ID: 2839529
[TBL] [Abstract][Full Text] [Related]
13. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
[TBL] [Abstract][Full Text] [Related]
14. Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study.
Ruaro B; Pizzorni C; Paolino S; Alessandri E; Sulli A
Front Pharmacol; 2019; 10():293. PubMed ID: 31019461
[TBL] [Abstract][Full Text] [Related]
15. Primary Headache and Helicobacter Pylori.
Gasbarrini A; De Luca A ; Fiore G; Franceschi F; Ojetti V; Torre ES; Di Campli C ; Candelli M; Pola R; Serricchio M; Tondi P; Gasbarrini G; Pola P; Giacovazzo M
Int J Angiol; 1998 Aug; 7(4):310-2. PubMed ID: 9716793
[TBL] [Abstract][Full Text] [Related]
16. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
[TBL] [Abstract][Full Text] [Related]
17. Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.
Black CM; Halkier-Sørensen L; Belch JJ; Ullman S; Madhok R; Smit AJ; Banga JD; Watson HR
Br J Rheumatol; 1998 Sep; 37(9):952-60. PubMed ID: 9783759
[TBL] [Abstract][Full Text] [Related]
18. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.
Ergül B; Doğan Z; Sarikaya M; Filik L
Helicobacter; 2013 Dec; 18(6):454-8. PubMed ID: 24011287
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori prevalence in Raynaud's disease].
Hervé F; Cailleux N; Benhamou Y; Ducrotté P; Lemeland JF; Denis P; Marie I; Lévesque H
Rev Med Interne; 2006 Oct; 27(10):736-41. PubMed ID: 16978744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
